Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 21269271)

1.

WT1 and its transcriptional cofactor BASP1 redirect the differentiation pathway of an established blood cell line.

Goodfellow SJ, Rebello MR, Toska E, Zeef LA, Rudd SG, Medler KF, Roberts SG.

Biochem J. 2011 Apr 1;435(1):113-25. doi: 10.1042/BJ20101734.

2.

Repression of transcription by WT1-BASP1 requires the myristoylation of BASP1 and the PIP2-dependent recruitment of histone deacetylase.

Toska E, Campbell HA, Shandilya J, Goodfellow SJ, Shore P, Medler KF, Roberts SG.

Cell Rep. 2012 Sep 27;2(3):462-9. doi: 10.1016/j.celrep.2012.08.005. Epub 2012 Aug 30.

3.

Dynamic interaction between WT1 and BASP1 in transcriptional regulation during differentiation.

Green LM, Wagner KJ, Campbell HA, Addison K, Roberts SG.

Nucleic Acids Res. 2009 Feb;37(2):431-40. doi: 10.1093/nar/gkn955. Epub 2008 Dec 2.

4.

Prohibitin is required for transcriptional repression by the WT1-BASP1 complex.

Toska E, Shandilya J, Goodfellow SJ, Medler KF, Roberts SG.

Oncogene. 2014 Oct 23;33(43):5100-8. doi: 10.1038/onc.2013.447. Epub 2013 Oct 28.

5.

BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1.

Carpenter B, Hill KJ, Charalambous M, Wagner KJ, Lahiri D, James DI, Andersen JS, Schumacher V, Royer-Pokora B, Mann M, Ward A, Roberts SG.

Mol Cell Biol. 2004 Jan;24(2):537-49.

6.

Role of WT1-ZNF224 interaction in the expression of apoptosis-regulating genes.

Montano G, Cesaro E, Fattore L, Vidovic K, Palladino C, Crescitelli R, Izzo P, Turco MC, Costanzo P.

Hum Mol Genet. 2013 May 1;22(9):1771-82. doi: 10.1093/hmg/ddt027. Epub 2013 Jan 28.

7.

Transcriptional regulation by the Wilms' tumour suppressor protein WT1.

Wagner KJ, Roberts SG.

Biochem Soc Trans. 2004 Dec;32(Pt 6):932-5.

PMID:
15506928
8.

Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.

Vidovic K, Svensson E, Nilsson B, Thuresson B, Olofsson T, Lennartsson A, Gullberg U.

Leukemia. 2010 May;24(5):992-1000. doi: 10.1038/leu.2010.33. Epub 2010 Mar 18.

PMID:
20237505
9.

Deregulation of the Wilms' tumour gene 1 protein (WT1) by BCR/ABL1 mediates resistance to imatinib in human leukaemia cells.

Svensson E, Vidovic K, Lassen C, Richter J, Olofsson T, Fioretos T, Gullberg U.

Leukemia. 2007 Dec;21(12):2485-94. Epub 2007 Aug 30.

PMID:
17728783
10.

Characterization of BASP1-mediated neurite outgrowth.

Korshunova I, Caroni P, Kolkova K, Berezin V, Bock E, Walmod PS.

J Neurosci Res. 2008 Aug 1;86(10):2201-13. doi: 10.1002/jnr.21678.

PMID:
18438920
11.

Regulated expression of the alpha isoform of the human thromboxane A2 receptor during megakaryocyte differentiation: a coordinated role for WT1, Egr1, and Sp1.

Gannon AM, Turner EC, Reid HM, Kinsella BT.

J Mol Biol. 2009 Nov 20;394(1):29-45. doi: 10.1016/j.jmb.2009.09.007. Epub 2009 Sep 8.

PMID:
19747485
12.
13.

Inhibitory mechanism of pure curcumin on Wilms' tumor 1 (WT1) gene expression through the PKCα signaling pathway in leukemic K562 cells.

Semsri S, Krig SR, Kotelawala L, Sweeney CA, Anuchapreeda S.

FEBS Lett. 2011 Jul 21;585(14):2235-42. doi: 10.1016/j.febslet.2011.05.043. Epub 2011 Jun 7.

14.

Biochemical and functional interaction between ZNF224 and ZNF255, two members of the Kruppel-like zinc-finger protein family and WT1 protein isoforms.

Florio F, Cesaro E, Montano G, Izzo P, Miles C, Costanzo P.

Hum Mol Genet. 2010 Sep 15;19(18):3544-56. doi: 10.1093/hmg/ddq270. Epub 2010 Jun 30.

15.

Anlaysis of complementary expression profiles following WT1 induction versus repression reveals the cholesterol/fatty acid synthetic pathways as a possible major target of WT1.

Rae FK, Martinez G, Gillinder KR, Smith A, Shooter G, Forrest AR, Grimmond SM, Little MH.

Oncogene. 2004 Apr 15;23(17):3067-79.

PMID:
15021918
16.

A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines.

Algar EM, Khromykh T, Smith SI, Blackburn DM, Bryson GJ, Smith PJ.

Oncogene. 1996 Mar 7;12(5):1005-14.

PMID:
8649791
17.

The Wilms' tumor suppressor Wt1 is associated with the differentiation of retinoblastoma cells.

Wagner N, Wagner KD, Schley G, Coupland SE, Heimann H, Grantyn R, Scholz H.

Cell Growth Differ. 2002 Jul;13(7):297-305.

18.
19.

Nuclear topography and expression of the BCR/ABL fusion gene and its protein level influenced by cell differentiation and RNA interference.

Bártová E, Harnicarová A, Pacherník J, Kozubek S.

Leuk Res. 2005 Aug;29(8):901-13. Epub 2005 Mar 5.

PMID:
15978941
20.

Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival.

Renshaw J, Orr RM, Walton MI, Te Poele R, Williams RD, Wancewicz EV, Monia BP, Workman P, Pritchard-Jones K.

Mol Cancer Ther. 2004 Nov;3(11):1467-84.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk